Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 18,549 | 18,414 | 17,067 | 14,225 | 13,412 |
| Gross Profit | 18,549 | 18,414 | 17,067 | 14,225 | 13,412 |
| Operating Expenses | 101,658 | 92,881 | 86,449 | 68,848 | 60,191 |
| Operating Income | -83,109 | -74,467 | -69,382 | -54,623 | -46,779 |
| Other Income | 7,004 | 8,777 | 761 | 11,315 | -8,354 |
| Pre-tax Income | -76,105 | -65,690 | -68,621 | -43,308 | -55,133 |
| Net Income Continuous | -76,105 | -65,690 | -68,621 | -43,308 | -55,133 |
| Net Income | $-76,105 | $-65,690 | $-68,621 | $-43,308 | $-55,133 |
| EPS Basic Total Ops | -0.79 | -0.68 | -0.73 | -0.45 | -0.58 |
| EPS Basic Continuous Ops | -0.79 | -0.68 | -0.72 | -0.45 | -0.58 |
| EPS Diluted Total Ops | -0.79 | -0.68 | -0.73 | -0.45 | -0.58 |
| EPS Diluted Continuous Ops | -0.79 | -0.68 | -0.72 | -0.45 | -0.58 |
| EBITDA(a) | $-79,953 | $-69,739 | $-64,817 | $-50,632 | $-43,145 |